ADM KOREA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,490 KRW | -2.92% |
|
-6.56% | +80.08% |
| Sales 2022 | 14.88B 10.75M 896M | Sales 2023 | 13.79B 9.96M 830M | Capitalization | 44.18B 31.9M 2.66B |
|---|---|---|---|---|---|
| Net income 2022 | 267M 193K 16.08M | Net income 2023 | -2.97B -2.14M -179M | EV / Sales 2022 | 0.61 x |
| Net cash position 2022 | 34.43B 24.86M 2.07B | Net cash position 2023 | 18.28B 13.2M 1.1B | EV / Sales 2023 | 1.88 x |
| P/E ratio 2022 |
166
x | P/E ratio 2023 |
-13.8
x | Employees | 186 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.67% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.92% | ||
| 1 week | -6.56% | ||
| Current month | +4.02% | ||
| 1 month | +4.02% | ||
| 3 months | +43.33% | ||
| 6 months | +96.07% | ||
| Current year | +80.08% |
1 week
3 445.00
3 670.00
1 month
2 950.003 810.00
Current year
1 922.003 820.00
1 year
1 710.003 820.00
3 years
1 710.0011 000.00
5 years
1 710.0011 000.00
10 years
1 710.0011 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jong-Eon Lim
CEO | Chief Executive Officer | 40 | - |
Do-Hyeong Na
BRD | Director/Board Member | 57 | - |
Hyun-Woo Kim
BRD | Director/Board Member | 47 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jong-Yoon Lee
BRD | Director/Board Member | 56 | - |
Ji-Heon Kim
BRD | Director/Board Member | 57 | - |
Geun-Chang Lee
BRD | Director/Board Member | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 3,490 | -2.92% | 236,341 |
| 29/24/29 | 3,595 | +1.41% | 243,724 |
| 26/24/26 | 3,545 | +0.85% | 160,679 |
| 25/24/25 | 3,515 | +0.57% | 245,344 |
| 24/24/24 | 3,495 | -3.45% | 348,602 |
End-of-day quote Korea S.E., April 30, 2024
More quotes
ADM Korea Inc is a Korea-based company primarily engaged in the provision of clinical trial services. The Company is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The Company also provides post-marketing research (rPMS) services.
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +80.08% | 53.34M | |
| +0.67% | 42.19B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +6.55% | 24.63B | |
| -21.66% | 18.2B | |
| +29.96% | 12.01B | |
| -1.57% | 11.76B | |
| +16.03% | 10.4B | |
| -4.80% | 9.94B |
- Stock Market
- Equities
- A187660 Stock
